NYSE:CO Global Cord Blood (CO) Stock Forecast, Price & News $2.99 +0.77 (+34.68%) (As of 09/23/2022) Add Compare Share Share Today's Range$2.21▼$3.3250-Day Range$2.99▼$2.9952-Week Range$2.03▼$5.50Volume9.28 million shsAverage Volume216,519 shsMarket CapitalizationN/AP/E Ratio4.67Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Global Cord Blood (NYSE:CO) StockGlobal Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Read More Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Stock News HeadlinesMay 24, 2023 | finance.yahoo.comBiobanking Market worth $5.0 billion | MarketsandMarketsMay 22, 2023 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Now Covered by StockNews.comMay 29, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 18, 2023 | msn.com830 WCCO Be The Match Radio AuctionMay 17, 2023 | marketwatch.comStem Cell Umbilical Cord Blood Market Upto 2030May 13, 2023 | marketwatch.comCord Blood Stem Cells Market | 2030May 13, 2023 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.comMay 13, 2023 | marketwatch.com2023 Cord Blood Banking Services Market Price & News with Size Forecast 2030May 29, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 12, 2023 | marketwatch.comGlobal Cord Blood Banking Service Market Analysis: Insights, Production Processes, Market Strategies, and Future OutlookMay 12, 2023 | marketwatch.comCord Blood Banking Market Size and volume sale report 2023May 10, 2023 | marketwatch.comCord Blood Banking Services Market Forthcoming Trends and Share Analysis by 2031May 9, 2023 | marketwatch.comStem Cell Umbilical Cord Blood Market with Business Application till 2030May 9, 2023 | marketwatch.comUmbilical Cord Blood Banking Market Research, 2030May 8, 2023 | marketwatch.comTechnological Advancements and Regional Cord Blood Banking Market Size Report 2023-2029May 5, 2023 | marketwatch.comUmbilical Cord Blood (UCB) Stem Cell Market [2023-2030] | Global Size and Growth DevelopmentsMay 5, 2023 | marketwatch.comGlobal Cord Blood Banking Services Market [2023] | Report Highlights Industry Potential to Reach USD 42415.92 Million by 2030May 4, 2023 | marketwatch.comStem Cell Umbilical Cord Blood Market Insight [2023-2030] Latest Research Report by Marketreportsworld.comMay 3, 2023 | marketwatch.com2023-2030 Cord Blood Bank Market Size (Growth and Outlook) includes Revenue Analysis | with [113 Pages]April 29, 2023 | marketwatch.comUmbilical Cord Blood (UCB) Stem Cell Market Complete Overview till 2031April 27, 2023 | marketwatch.comCord Blood Banking Market Research, 2023-2030April 27, 2023 | americanbankingnews.comGlobal Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.comApril 24, 2023 | marketwatch.comGlobal Umbilical Cord Blood Banking Market [2023] | Industry Poised for Steady Growth with 21.13% CAGR and USD 40745.01 Million Revenue by 2030April 23, 2023 | marketwatch.com2023-2029 "Umbilical Cord Blood Banking Market" Share, With 99+ Pages By IRBApril 19, 2023 | marketwatch.comGlobal Stem Cell Therapy Market Size to Reach USD 1,185.9 Million in 2030April 19, 2023 | marketwatch.comFuture of Umbilical Cord Blood Banking Market 2023-2030 by size and ShareApril 16, 2023 | marketwatch.com2023-2029 "Cord Blood Banking Services Market" Trend, With 121+ Pages By IRBSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Company Calendar Last Earnings6/26/2018Today5/28/2023Next Earnings (Estimated)7/04/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:CO CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio4.67 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$196.12 million Price / SalesN/A Cash Flow$0.71 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.47Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable Beta-0.04 Key ExecutivesTing ZhengChairman & Chief Executive OfficerBing Chuen ChenChief Financial Officer & DirectorXin XuChief Technology OfficerRui ArashiyamaCEO-Guangdong & Zhejiang DivisionsKey Competitors111NASDAQ:YIAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWAlvotechNASDAQ:ALVOWView All CompetitorsInstitutional OwnershipClark Financial Services Group Inc. BDBought 12,275 shares on 5/12/2023Ownership: 0.010%Simplex Trading LLCSold 7,700 shares on 4/27/2023Ownership: 0.000%View All Institutional Transactions CO Stock - Frequently Asked Questions How have CO shares performed in 2023? Global Cord Blood's stock was trading at $2.9876 at the beginning of the year. Since then, CO stock has increased by 0.1% and is now trading at $2.99. View the best growth stocks for 2023 here. When is Global Cord Blood's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 4th 2023. View our CO earnings forecast. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) released its quarterly earnings data on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL). What is Global Cord Blood's stock symbol? Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO." Who are Global Cord Blood's major shareholders? Global Cord Blood's stock is owned by many different institutional and retail investors. Top institutional investors include Clark Financial Services Group Inc. BD (0.01%) and Simplex Trading LLC (0.00%). View institutional ownership trends. How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Global Cord Blood's stock price today? One share of CO stock can currently be purchased for approximately $2.99. How many employees does Global Cord Blood have? The company employs 1,202 workers across the globe. How can I contact Global Cord Blood? Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181. This page (NYSE:CO) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.